Skip to main content

When to Pace in Congenital AV Block

 

Pacing in Congenital Atrioventricular (AV) Block: A Practical Clinical Overview


Congenital atrioventricular (AV) block is a rare but important bradyarrhythmia seen in newborns, children, and sometimes first diagnosed in adults. Management varies depending on symptoms, ventricular function, and the presence of associated structural heart disease. Pacing remains the cornerstone of treatment for most clinically significant cases.



---


What Is Congenital AV Block?


Congenital AV block is defined as third-degree (or advanced second-degree) AV block diagnosed:


In utero,


At birth, or


During the first month of life,

in the absence of a reversible cause.



It may occur:


Isolated (most common), often due to maternal autoimmune antibodies (anti-Ro/SSA, anti-La/SSB).


With structural congenital heart disease, such as L-TGA (cc-TGA), atrial isomerism, or AV septal defects.




---


When Is Pacing Needed?


The decision to implant a permanent pacemaker depends on multiple factors. Major guideline-driven indications include:


1. Symptomatic Bradycardia


Fatigue, exercise intolerance


Feeding difficulty in infants


Syncope or pre-syncope



2. Ventricular Dysfunction


Even if asymptomatic, LV dilatation or reduced EF suggests chronic dyssynchrony and mandates pacing.


3. Ventricular Rates Below Age-Based Thresholds


Typical pacing thresholds:


Infants: HR < 55 bpm (or < 70 bpm if structural heart disease)


Children/Adolescents: Persistent low intrinsic rate causing chronotropic incompetence


Fetal bradycardia (< 55 bpm) → high mortality, often needs close monitoring and post-natal pacemaker



4. Wide QRS Escape Rhythm


Suggests unstable or distal escape focus → pacing is preferred.


5. Pauses or Ventricular Ectopy


Recurrent long pauses, ventricular escape instability, or frequent PVCs indicate the need for pacing.


6. Requirement for Improved Cardiac Output


Especially important in:


Neonates with compromised hemodynamics


Athletes with chronotropic limitation


Patients with associated cardiomyopathy




---


Types of Pacing Used in Congenital AV Block


1. Epicardial Pacing (Infants & Young Children)


Preferred in neonates/infants due to small venous size.


Leads placed surgically on the epicardial surface.


Slightly higher lead failure rates but safe long term.



2. Transvenous Endocardial Pacing (Older Children & Adults)


Used once body size allows.


Better lead longevity


Simpler revisions



3. Dual-Chamber (DDD) Pacing


Most commonly used, maintains AV synchrony, prevents pacemaker-induced cardiomyopathy.


4. Physiologic Pacing (HBP / LBBP)


Increasingly preferred to avoid dyssynchrony:


His bundle pacing (HBP)


Left bundle branch pacing (LBBP)

Improves long-term ventricular function, especially important in lifelong pacing.



5. Cardiac Resynchronization Therapy (CRT)


Indicated when:


LV dysfunction already present


High pacing burden expected with wide QRS


Epicardial lead options limited




---


Special Considerations in Congenital AV Block


1. Maternal Autoimmune Antibodies


Infants exposed to anti-Ro/SSA have higher risk of progressive conduction disease.

Even those born with stable block require lifelong follow-up.


2. Growth and Lead Longevity


Children outgrow leads → expect multiple generator and lead revisions through life.


3. Exercise & Chronotropic Response


Modern pacing systems (rate-responsive, physiologic pacing) improve exercise capacity and quality of life.


4. Pregnancy Considerations (in adult women with congenital AV block)


Pacing usually adequate; monitor for:


Increased pacing burden


Lead fatigue


Cardiomyopathy in those with RV apical pacing




---


Long-Term Outcomes


With timely pacing:


Survival approaches normal


LV function preserved with physiologic pacing


Quality of life excellent in most patients



Delayed or absent pacing increases:


Risk of sudden cardiac death


Cardiomyopathy due to prolonged bradycardia


Poor neurodevelopment in infants due to low cardiac output




---


Key Takeaways


Congenital AV block requires lifelong follow-up, even if asymptomatic.


Pacing is indicated for symptoms, ventricular dysfunction, low heart rate thresholds, or unstable escape rhythms.


Physiologic pacing (HBP/LBBP) is increasingly preferred to prevent dyssynchrony and preserve LV function.


Early intervention dramatically improves long-term outcomes.


Comments

  1. I was diagnosed with Idiopathic Pulmonary Fibrosis (IPF) four years ago, and even with different treatments, my symptoms kept getting worse. Last year, I turned to the herbal program from NaturePath Herbal Clinic, and they helped me by providing a natural treatment plan that improved my breathing, reduced my fatigue, and boosted my overall energy. The difference has been incredible. If you’d like to learn more, here are their links:
    www.naturepathherbalclinic.com
    info@naturepathherbalclinic.com

    ReplyDelete

Post a Comment

Drop your thoughts here, we would love to hear from you

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.